Synapse - Works

Results (4073)

Efficacy and safety of abiraterone acetate (AA) in elderly (75 years) chemo-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Smith, M. R.; Rathkopf, D.; Mulders, P.; Carles, J.; Van Poppel, H.; Li, J.; Kheoh, T.; Griffin, T.; Molina, A.; Ryan, C.
European Journal of Cancer (2013)

Fulltext@MSK | Save

ARN-509 in men with high risk non-metastatic castration-resistant prostate cancer

Meeting Abstract

Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Alumkal, J. J.; Higano, C. S.; Maneval, E. C.; Rathkopf, D. E.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Initial results of a new antibody-drug conjugate (ADC), IMMU-130 (labetuzumab-SN38), in patients with metastatic colorectal cancer (mCRC)

Meeting Abstract

Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Evaluation of a composite biomarker panel including circulating tumor cell (CTC) enumeration as a surrogate for survival in metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Scher, H. I.; Heller, G.; Molina, A.; Attard, G.; McCormack, R.; Riisnaes, R.; Kheoh, T.; Fleisher, M.; Buyse, M.; de Bono, J. S.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 AFFIRM trial comparing enzalutamide to placebo

Meeting Abstract

Scher, H.; Fizazi, K.; Sternberg, C. N.; Armstrong, A.; Bhattacharya, S.; Hirmand, M.; de Bono, J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Androgen receptor (AR) and AR-signaling directed therapies in the age of precision medicine

Meeting Abstract

Scher, H.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Quality of life improves after placement of percutaneous tunneled drainage catheter for refractory ascites in prospective study of patients with end stage cancer

Meeting Abstract

Robson, P. C.; Jia, X.; Gonen, M.; Kline, N.; Thom, B.; Brody, L. A.; Brown, K. T.; Getrajdman, G.; Kennedy, M.; Covey, A. M.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Phase I trial evaluating concurrent vemurafenib and ipilimumab in patients with advanced BRAF-mutant melanoma

Meeting Abstract

Ribas, A.; Hodi, F. S.; Callahan, M.; Chmielowski, B.; Lawrence, D.; Konto, C.; McHenry, M. B.; Choong, N.; Wolchok, J.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Measuring pros that matter to bariatric and body contouring surgery: The body-q

Meeting Abstract

Pusic, A.; Cano, S.; Scott, A.; Tsangaris, E.; Klassen, A.
Value in Health (2013)

Fulltext@MSK | Save

HER2 tissue expression in NeuACT, a phase 2, randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Hoffman-Censits, J.; Quinn, D. I.; Sharma, P.; DeVries, T.; Chen, M.; Locker, M.; Bajorin, D. F.
European Journal of Cancer (2013)

Fulltext@MSK | Save